Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
4(100.0%)
4Total
Phase 2(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00350766Phase 2Terminated

Cell Therapy in Myocardial Infarction

Role: collaborator

NCT02394236Phase 2Completed

Aerobic Exercise and Oxygen Uptake Efficiency Slope in Coronary Artery Disease

Role: lead

NCT02106533Phase 2Completed

Aerobic Exercise on Ventilatory Efficiency in CAD Patients

Role: lead

NCT01515033Phase 2Completed

Aerobic Exercise on PETCO2 Response in Coronary Artery Disease Patients

Role: lead

All 4 trials loaded